1. Home
  2. EOLS vs MATV Comparison

EOLS vs MATV Comparison

Compare EOLS & MATV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EOLS
  • MATV
  • Stock Information
  • Founded
  • EOLS 2012
  • MATV 1995
  • Country
  • EOLS United States
  • MATV United States
  • Employees
  • EOLS N/A
  • MATV N/A
  • Industry
  • EOLS Biotechnology: Pharmaceutical Preparations
  • MATV Paper
  • Sector
  • EOLS Health Care
  • MATV Basic Materials
  • Exchange
  • EOLS Nasdaq
  • MATV Nasdaq
  • Market Cap
  • EOLS 787.7M
  • MATV 659.1M
  • IPO Year
  • EOLS 2018
  • MATV 1995
  • Fundamental
  • Price
  • EOLS $11.35
  • MATV $11.71
  • Analyst Decision
  • EOLS Strong Buy
  • MATV Hold
  • Analyst Count
  • EOLS 6
  • MATV 1
  • Target Price
  • EOLS $22.60
  • MATV $15.50
  • AVG Volume (30 Days)
  • EOLS 504.4K
  • MATV 421.7K
  • Earning Date
  • EOLS 11-06-2024
  • MATV 11-06-2024
  • Dividend Yield
  • EOLS N/A
  • MATV 3.34%
  • EPS Growth
  • EOLS N/A
  • MATV N/A
  • EPS
  • EOLS N/A
  • MATV 1.97
  • Revenue
  • EOLS $248,326,000.00
  • MATV $1,974,800,000.00
  • Revenue This Year
  • EOLS $33.43
  • MATV $1.88
  • Revenue Next Year
  • EOLS $32.44
  • MATV $2.37
  • P/E Ratio
  • EOLS N/A
  • MATV $6.04
  • Revenue Growth
  • EOLS 34.42
  • MATV N/A
  • 52 Week Low
  • EOLS $9.65
  • MATV $10.78
  • 52 Week High
  • EOLS $17.82
  • MATV $19.96
  • Technical
  • Relative Strength Index (RSI)
  • EOLS 35.09
  • MATV 39.30
  • Support Level
  • EOLS $11.34
  • MATV $11.80
  • Resistance Level
  • EOLS $11.83
  • MATV $12.37
  • Average True Range (ATR)
  • EOLS 0.46
  • MATV 0.47
  • MACD
  • EOLS -0.00
  • MATV 0.05
  • Stochastic Oscillator
  • EOLS 14.41
  • MATV 22.44

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

About MATV Mativ Holdings Inc.

Mativ Holdings Inc is a diversified producer of premium specialty papers and resin-based products. It manufactures and sells paper and reconstituted tobacco products to the tobacco industry as well as specialized paper products. The company operates in two segments namely Advanced Materials and Structures, which manufactures resin-based products used in specialty applications in the filtration, infrastructure and construction, transportation, industrial, and medical end-markets, and Engineered Papers, which produces cigarette papers and reconstituted tobacco products for cigarette and cigar manufacturers, as well as various other non-tobacco paper products.

Share on Social Networks: